Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: Randomized controlled trial

British Journal of Nutrition

Volumn 101, Issue 6, 2009, Pages 886-894

  Brown, A Louise ^a   Lane, Joan ^a   Coverly, Jacqueline ^a   Stocks, Janice ^a   Jackson, Sarah ^b   Stephen, Alison ^b   Bluck, Les ^b   Coward, Andy ^b   Hendrickx, Hilde ^a  

^a UNILEVER RESEARCH   (United Kingdom)

^b MRC HUMAN NUTRITION RESEARCH   (United Kingdom)

Author keywords

Blood pressure; Cardiovascular disease; Catechin; Obesity; Type 2 diabetes

Indexed keywords

EPIGALLOCATECHIN GALLATE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; LACTOSE; LOW DENSITY LIPOPROTEIN; PLACEBO;

ADULT; AGED; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CARDIOVASCULAR EFFECT; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; GLUCOSE TOLERANCE; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MOOD CHANGE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TEA; WAIST CIRCUMFERENCE;

ADULT; AFFECT; AGED; ANTIHYPERTENSIVE AGENTS; CATECHIN; DIASTOLE; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PHYTOTHERAPY; TREATMENT FAILURE;

ANIMALIA;

EID: 67649422274     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114508047727     Document Type: Article

References (55)

1. Lebovitz HE (2006) Insulin resistance - a common link between type 2 diabetes and cardiovascular disease. Diabetes Obes Metab 8, 237-249.
2. Kahn N & Mukhtar H (2007) Tea polyphenols for health promotion. Life Sci 81, 519-533.
3. Kao YH, Chang HH, Lee MJ & Chen CL (2006) Tea, obesity, and diabetes. Mol Nutr Food Res 50, 188-210.
4. Murase T, Nagasawa A, Suzuki J, Hase T & Tokimitsu I (2002) Beneficial effects of tea catechins on diet-induced obesity: Stimulation of lipid catabolism in the liver. Int J Obes 26, 1459-1464.
5. Wu LY, Juan CC, Hwang LS, Hsu YP, Ho PH & Ho LT (2004) Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model. Eur J Nutr 43, 116-124.
6. Wu LY, Juan CC, Ho LT, Hsu YP & Hwang LS (2004) Effect of green tea supplementation on insulin sensitivity in SpragueDawley rats. J Agric Food Chem 52, 643-648.
7. Hosoda K, Wang MF, Liao ML, Chuang CK, Iha M, Clevidence B & Yamamoto S (2003) Antihyperglycentic effect of oolong tea in type 2 diabetes. Diabetes Care 26, 1714-1718.
8. Tsuneki H, Ishizuka M, Terasawa M, Wu JB, Sasaoka T & Kimura I (2004) Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BMC Pharmacol 4, 18.
9. Broadhurst CL, Polansky MM & Anderson RA (2000) Insulinlike biological activity of culinary and medicinal plant aqueous extracts in vitro. J Agric Food Chem 48, 849-852.
10. Anderson RA & Polansky MM (2002) Tea enhances insulin activity. J Agric Food Chem 50, 7182-7186.
11. Potenza MA, Marasciulo FL, Tarquinio M, Tiravanti E, Colantuono G, Federici A, Kim JA, Quon MJ & Montagnani M (2007) EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab 292, E1378-E1387.
12. Wolfram S, Raederstorff D, Preller M, Wang Y, Teixeira SR, Riegger C & Weber P (2006) Epigallocatechin gallate supplementation alleviates diabetes in rodents. J Nutr 136, 2512-2518.
13. Chen PC, Wheeler DS, Malhotra V, Odoms K, Denenberg AG & Wong HR (2002) A green tea-derived polyphenol, epigallocatechin- 3-gallate, inhibits I kappa B kinase activation and IL-8 gene expression in respiratory epithelium. Inflammation 26, 233-241.
14. Pan MH, Lin-Shiau SY, Ho CT, Lin JH & Lin JK (2000) Suppression of lipopolysaccharide-induced nuclear factor-kappa B activity by theaflavin-3,3′-digallate from black tea and other polyphenols through down-regulation of I kappa B kinase activity in macrophages. Biochem Pharmacol 59, 357-367.
15. Yang FJ, Oz HS, Barve S, De Villiers WJS, McClain CJ & Varilek GW (2001) The green tea polyphenol (-)-epigallocatechin- 3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. Mol Pharmacol 60, 528-533.
16. Shoelson SE, Lee J & Yuan M (2003) Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and dietinduced insulin resistance. Int J Obes 27, S49-S52.
17. Tamura Y, Ogihara T, Uchida T, et al. (2007) Amelioration of glucose tolerance by hepatic inhibition of nuclear factor kappa B in db/ db mice. Diabetologia 50, 131-141.
18. Adachi N, Tomonaga S, Tachibana T, Denbow DM & Furuse M (2006) (-)-Epigallocatechin gallate attenuates acute stress responses through GABAergic system in the brain. Eur J Pharmacol 531, 171-175.
19. Vignes M, Maurice T, Lante F, Nedjar M, Thethi Y, Guiramand J & Recasens M (2006) Anxiolytic properties of green tea polyphenol (-)-epigallocatechin gallate (EGCG). Brain Res 1110, 102-115.
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC (1985) Homeostasis model assessment - insulin resistance and beta-cell function from fasting plasma-glucose and insulin concentrations in man. Diabetologia 28, 412-419.
21. Matsuda M & DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing - comparison with the euglycemic insulin clamp. Diabetes Care 22, 1462-1470.
22. Phillips DIW, Clark PM, Hales CN & Osmond C (1994) Understanding oral glucose-tolerance - comparison of glucose or insulin measurements during the oral glucose-tolerance test with specific measurements of insulin-resistance and insulin-secretion. Diabetes Med 11, 286-292.
23. Price GM, Paul AA, Key FB, Harter AC, Cole TJ, Day KC & Wadsworth MEJ (1995) Measurement of diet in a large national survey: Comparison of computerised and manual coding in household measures. J Hum Nutr Diet 8, 417-428.
24. Foods Standards Agency (2002) McCance and Widdowson's The Composition of Food, 6th ed. Cambridge: Royal Society of Chemistry.
25. Matthews G, Jones DM & Chamberlain AG (1990) Refining the measurement of mood - the UWIST mood adjective checklist. Br J Psychol 81, 17-42.
26. Svedlund J, Sjodin I & Dotevall G (1988) GSRS - a clinical rating-scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic-ulcer disease. Digest Dis Sci 33, 129-134.
27. Laakso M (1993) How good a marker is insulin level for insulin-resistance. Am J Epidemiol 137, 959-965.
28. Genuth S, Alberti KGMM, Bennett P, et al. (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26, 3160-3167.
29. Khokhar S & Magnusdottir SGM (2002) Total phenol, catechin, and caffeine contents of teas commonly consumed in the United Kingdom. J Agric Food Chem 50, 565-570.
30. Fukino Y, Shimbo M, Aoki N, Okubo T & Iso H (2005) Randomized controlled trial for an effect of green tea consumption on insulin resistance and inflammation markers. J Nutr Sci Vitaminol 51, 335-342.
31. Fukino, Y, Ikeda A, Maruyama K, Aoki N, Okubo T & Iso H (2007) Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur J Clin Nutr (Epublication ahead of print version 6 June 2007).
32. Chan CCW, Koo MWL, Ng EHY, Tang OS, Yeung WSB & Ho PC (2006) Effects of Chinese green tea on weight, and hormonal and biochemical profiles in obese patients with polycystic ovary syndrome - a randomized placebo-controlled trial. J Soc Gynecol Invest 13, 63-68.
33. Ryu OH, Lee J, Lee KW, Kim HY, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS & Choi KM (2006) Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes Res Clin Prac 71, 356-358.
34. Feng WY (2006) Metabolism of green tea catechins: An overview. Curr Drug Metab 7, 755-809.
35. Waltner-Law ME, Wang XHL, Law BK, Hall RK, Nawano M & Granner DK (2002) Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. J Biol Chem 277, 34933-34940.
36. Cook NR, Cohen J, Hebert PR, Taylor JO & Hennekens CH (1995) Implications of small reductions in diastolic blood-pressure for primary prevention. Arch Intern Med 155, 701-709.
37. Yang YC, Lu FH, Wu JS, Wu CH & Chang CJ (2004) The protective effect of habitual tea consumption on hypertension. Arch Intern Med 164 1534-1540.
38. Henry JP & Stephenslarson P (1984) Reduction of chronic psychosocial hypertension in mice by decaffeinated tea. Hypertension 6, 437-444.
39. Negishi H, Xu JW, Ikeda K, Njelekela M, Nara Y & Yamori Y (2004) Black and green tea polyphenols attenuate blood pressure increases in stroke-prone spontaneously hypertensive rats. J Nutr 134, 38-42.
40. Lorenz M, Wessler S, Follmann E, Michaelis W, Dusterhoft T, Baumann G, Stangl K & Stangl V (2004) A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation. J Biol Chem 279, 6190-6195.
41. Persson IA, Josefsson M, Persson K & Andersson RG (2006) Tea flavanols inhibit angiotensin-converting enzyme activity and increase nitric oxide production in human endothelial cells. J Pharm Pharmacol 58, 1139-1144.
42. Kim JA, Formoso G, Li YH, Potenza MA, Marasciulo FL, Montagnani M & Quon MJ (2007) Epigallocatechin gallate, a green tea polyphenol, mediates NO-dependent vasodilation using signaling pathways in vascular endothelium requiring reactive oxygen species and Fyn. J Biol Chem 282, 13736-13745.
43. Kim F, Tysseling KA, Rice J, Gallis B, Haji L, Giachelli CM, Raines EW, Corson MA & Schwartz MW (2005) Activation of IKK beta by glucose is necessary and sufficient to impair insulin signaling and nitric oxide production in endothelial cells. J Mol Cell Cardiol 39, 327-334.
44. Kim F, Tysseling KA, Rice J, et al. (2005) Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKK beta. Arterioscler Thromb Vasc Biol 25, 989-994.
45. Pan MH, Lin-Shiau SY, Ho CT, Lin JH & Lin JK (2000) Suppression of lipopolysaccharide-induced nuclear factor-kappa B activity by theaflavin-3,3′-digallate from black tea and other polyphenols through down-regulation of I kappa B kinase activity in macrophages. Biochem Pharmacol 59, 357-367.
46. Tang WJ, Hu CP, Chen MF, Deng PY & Li YJ (2006) Epigallocatechin gallate preserves endothelial function by reducing the endogenous nitric oxide synthase inhibitor level. Can J Physiol Pharm 84, 163-171.
47. Widlansky ME, Hamburg NM, Anter E, Holbrook M, Kahn DF, Elliott JG, Keaney JF & Vita JA (2007) Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease. J Am Coll Nutr 26, 95-102.
48. Kim W, Jeong MH, Hong YJ, Ahn YK, Kim JH, Cho JG & Kang JC (2006) The effect of green tea on endothelial dysfunction and circulating endothelial progenitor cells in the chronic smoker. Am J Cardiol 97, 60D.
49. Nagaya N, Yamamoto H, Uematsu M, Itoh T, Nakagawa K, Miyazawa T, Kangawa K & Miyatake K (2004) Green tea reverses endothelial dysfunction in healthy smokers. Heart 90, 1485-1486.
50. Heiss C, Schroeter H, Balzer J, Kleinbongard P, Matern S, Sies H & Kelm M (2006) Endothelial function, nitric oxide, and cocoa flavanols. J Cardiovasc Pharm 47, S128-S135.
51. Suganuma M, Okabe S, Oniyama M, Tada Y, Ito H & Fujiki H (1998) Wide distribution of [H-3](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 19, 1771-1776.
52. Paladini AC, Marder M, Viola H, Wolfman C, Wasowski C & Medina JH (1999) Flavonoids and the central nervous system: From forgotten factors to potent anxiolytic compounds. J Pharm Pharmacol 51, 519-526.
53. Steptoe A, Gibson EL, Vounonvirta R, Williams ED, Hamer M, Rycroft JA, Erusalimsky JD & Wardle J (2007) The effects of tea on psychophysiological stress responsivity and post-stress recovery: A randomised double-blind trial. Psychopharmacology 190, 81-89.
54. Grassi D, Lippi C, Necozione S, Desideri G & Ferri C (2007) Short administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. Am J Clin Nutr 81, 611-614.
55. Grassi D, Necozione S, Lippi C, Croce G, Valeri L, Pasqualetti P, Desideri G, Blumberg JB & Ferri C (2005) Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension 46, 398-405.